Related Experiment Video
Updated: Oct 3, 2025
09:43
Microfluidic Chip Fabrication and Method to Detect Influenza
Published on: March 26, 2013
15.1K
Rapid and High-Throughput SARS-CoV-2 RNA Detection without RNA Extraction and Amplification by Using a Microfluidic
Yujin Chu1, Jiaoyan Qiu1, Yihe Wang1
1Institute of Marine Science and Technology, Shandong University, Qingdao, Shandong, 266237, P.R. China.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|February 15, 2022
Summary
This study presents a novel microfluidic biochip for rapid, ultrasensitive severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) RNA detection. The method bypasses RNA extraction and amplification, offering a faster diagnostic solution for viral infections.
Area of Science:
- Biotechnology
- Nanomaterials Science
- Molecular Diagnostics
Background:
- The global spread of SARS-CoV-2 necessitates rapid and high-throughput detection methods.
- Existing diagnostic techniques for SARS-CoV-2 RNA often require complex sample preparation, including RNA extraction and amplification, which are time-consuming and resource-intensive.
- There is a critical need for simplified, faster, and more sensitive diagnostic strategies to manage viral outbreaks effectively.
Purpose of the Study:
- To develop a novel microfluidic biochip-based strategy for the rapid and ultrasensitive detection of SARS-CoV-2 RNA.
- To eliminate the requirement for RNA extraction and amplification in the detection process.
- To establish a high-throughput and accurate diagnostic tool for SARS-CoV-2 RNA.
Main Methods:
- Development of a microfluidic biochip integrating specific SARS-CoV-2 RNA-probe DNA reactions.
- Utilization of nanomaterials for fluorescence signal regulation within microfluidic channels.
- Implementation of precise sample control mechanisms inherent to the microfluidic chip design.
- Simultaneous detection of multiple samples within a short timeframe.
Main Results:
- Achieved an ultralow limit of detection of 600 copies/mL with a broad linear detection range (1 aM to 100 fM).
- Successfully detected 15 samples simultaneously in just 40 minutes, omitting RNA purification and amplification steps.
- Validated detection accuracy against quantitative reverse transcription polymerase chain reaction (qRT-PCR), demonstrating a high recovery rate of 99-113%.
Conclusions:
- The developed microfluidic biochip strategy offers a rapid, ultrasensitive, and efficient method for SARS-CoV-2 RNA detection.
- This approach significantly simplifies the diagnostic workflow by removing the need for RNA extraction and amplification.
- The proposed strategy holds potential for quantitative diagnosis of viral infectious diseases, aiding in outbreak management and public health surveillance.
